Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ampersand Capital Partners
Manufacturing
CDMO Genezen expands to meet demand for viral vector production
As new CEO, Ray Kaczmarek is helping Indianapolis-based Genezen transition from a small networking firm to a full-fledged cell and gene therapy CDMO.
Kevin Dunleavy
Sep 17, 2021 8:50am
Germany's Vibalogics lays out $150M for Boston viral vector site
Nov 11, 2020 4:49pm
New CDMO, backed by private equity player, to make biologics
Oct 17, 2019 9:50am
Viral vector CDMO Vibalogics latest private equity target
May 30, 2019 9:52am